Pharmacy Courses

Brazil Pharma Market


Brazil is the largest pharmaceutical market in Central/Southern America and among top 10 pharma market in the world and the value is around USD 32 Bn. Their healthcare expenditure is about 13% of GDP.

Brazil import around USD 11.20 Bn among the top 20 pharmaceutical products importer in the world. Brazil imports Pharmaceutical products primarily from: USA, China, Switzerland, Belgium, and Germany. China, India, and Ireland are the main suppliers of API’s to Brazil.

The Medical Devices market size approx. USD 11.9 Bn, with CAGR of 6.9% while Brazil import of medical devices is approx. USD 6.2 Bn.

Brazilian market dominated by regional and domestic/national companies which lead the business and rank highly on the list of producers. Multinationals have chosen to acquire local companies as a strategy to enter the Brazilian market. 

Leading Pharmaceutical Companies in Brazil

  • Aché Laboratorios Farmaceuticos SA
  • Cristalia Produtos Quimicos Farmaceuticos Ltda (Cristália)
  • EMS Sigma
  • Eurofarma
  • GlaxoSmithKline
  • Medley Indústria Farmacêutica Ltda
  • Merck & Co. Inc. (MSD)
  • Novartis
  • Pfizer
  • Roche
  • Sanofi SA
  • NEO Quimica
  • Mantecorp Farmasa
  • Libbs
  • Biolab-Sanus Farma
  • Takeda
  • Libbs Farmaceutica
  • Teuto
  • União Farmacêutica and Vall

Top 10 Pharmacy Chain in Brazil

  •  Raia Drogasil - São Paulo
  • Pague Menos - Ceará
  • Drogaria São Paulo - São Paulo
  • Pacheco - Rio de Janeiro
  • Wal-Mart - São Paulo
  • Panvel - Rio Grande do Sul
  • Nissei - Paraná
  • Mais Econômica - Rio Grande do Sul
  • Big Ben - Pará
  • Imifarma - Pará

The most commonly prescribed drugs are for the treatment of chronic diseases like  – Blood pressure, Diabetes, Cardiovascular, Lower Respiratory Tract Infections, COPD, Obesity with high demand of Contraceptives, Rare Diseases, Generic Drugs and Infectious Diseases – HIV and Hepatitis C.

Major Challenges of Brazil Pharma Market

  • Distribution Network lies in the hands of a few national and regional groups Aggressive discount on specially on generic products.
  • Brazil requirements are relatively stringent compared to those of other Latin American countries. A drug approved in USA or EU is does not guarantee its approval in Brazil.

Read also: 

Resource Person: Dr. Palak Gupta

Previous Post Next Post